Screener
ANI Pharmaceuticals ANIP Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accrued government rebates | (1,762) | 14,152 |
| Returned goods reserve | (5,491) | 9,409 |
| Accrued expenses, accrued compensation, and other | (8,163) | (5,218) |
| Net Cash and Cash Equivalents Provided by Operating Activities | 115,044 | 110,803 |
| Cash Flows From Investing Activities | ||
| Acquisition of product rights, intangible assets, and other related assets | (5,250) | (20,267) |
| Acquisition of property and equipment, net | (9,128) | (6,488) |
| Net Cash and Cash Equivalents Used in Investing Activities | (14,378) | (26,755) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is ANI Pharmaceuticals's operating cash flow?
- ANI Pharmaceuticals (ANIP) reported operating cash flow of $56.67M in Q2 2026.
- How has ANI Pharmaceuticals's operating cash flow changed year-over-year?
- ANI Pharmaceuticals's operating cash flow decreased by 25.3% year-over-year, from $75.81M to $56.67M.
- What is the long-term trend for ANI Pharmaceuticals's operating cash flow?
- Over 2 years (2023 to 2025), ANI Pharmaceuticals's operating cash flow has grown at a 24.8% compound annual growth rate (CAGR), from $118.96M to $185.23M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about ANI Pharmaceuticals's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude